Highlights
- •Opsoclonus might be associated with cefepime neurotoxicity.
- •Cefepime neurotoxicity most commonly presents with myoclonus and encephalopathy.
- •Continuous video-EEG is vital to monitor for non-convulsive status epilepticus.
- •Cefepime neurotoxicity occurs in susceptible patients despite normal renal clearance.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins.Neuropharmacology. 2003; 45: 304-314
- Cefepime-induced neurotoxicity: a systematic review.Crit. Care. 2017; 21: 276
- Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.Crit. Care. 2013; 17: R264
- Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations.J. Neuroophthalmol. 2008; 28: 329-336
- Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies.JAMA Neurol. 2016; 73: 417-424
- A method for estimating the probability of adverse drug reactions.Clin. Pharmacol. Ther. 1981; 30: 239-245
- Cefepime-induced jaw myoclonus.Neurology. 2015; 84: 1183
- Cefixime-induced oculogyric crisis.Pediatr. Emerg. Care. 2012; 28: 55-56
Article info
Publication history
Published online: October 31, 2018
Accepted:
October 30,
2018
Received in revised form:
October 30,
2018
Received:
October 8,
2018
Identification
Copyright
© 2018 Elsevier B.V. All rights reserved.
